What were the key takeaways from Cellebrite DI's earnings call?

Did Cellebrite DI beat or miss consensus estimates last quarter?

What were the key takeaways from Cellebrite DI’s earnings call?

What guidance did Cellebrite DI's management provide for the next earnings period?

What is Cellebrite DI's gross profit margin?

What is the market's earnings forecast for Cellebrite DI next quarter?

What is the revenue and EPS growth rate for Cellebrite DI year over year?

What does Cellebrite DI do and what are its main business segments?

- **Record ARR Growth**: 21% YoY to $481M, driven by SaaS/cloud solutions (50%+ ARR growth) and Corellium acquisition. 
- **2026 Guidance**: 18-19% ARR growth, 19-20% revenue growth, and 26-27% EBITDA margin. 
- **Strategic Acquisitions**: SCG Canada for drone forensics ($15-20M price) and Corellium integration on track. 
- **Federal Recovery**: U.S. Federal unit to exceed company-wide growth, with 9PB storage contract in pipeline. 
- **AI Innovation**: Developing agentic applications for cold case investigations, targeting 2026 monetization. 
- **Free Cash Flow**: 34% margin in 2025, >30% in 2026.

**【CEO Summary Section】**
- **ARR Growth**: 21% YoY to $481 million, driven by strong adoption of SaaS/cloud solutions (50%+ ARR growth) and inorganic contributions from Corellium ($16.1M ARR at acquisition). 
- **Product Highlights**: 
  - 55% of installed base converted to Inseyets (vs. 50% target), with plans for additional 25%+ conversion in 2026. 
  - Guardian SaaS platform achieved 100%+ YoY growth for 6 straight quarters. 
  - Acquired SCG Canada for drone forensics capabilities, targeting $53B global drone market. 
- **Strategic Moves**: 
  - Completed Corellium acquisition, transitioning from reseller to integrated sales. 
  - Expanded go-to-market team by 20%, with focus on targeted defense/intel solutions. 
  - Launched Guardian Investigate in Q2 2026, enabling multi-data source criminal investigations. 
- **2026 Outlook**: 
  - ARR growth of 18-19% (vs. 17% in 2025), driven by federal market recovery, Inseyets conversions, and Corellium adoption. 
  - AI initiatives expected to improve operational efficiency and customer retention. 

**【CFO Financial Commentary】**
- **Q4 2025 Results**: 
  - Revenue: $128.8M (+18% YoY) 
  - Gross Margin: 86% 
  - Adjusted EBITDA: $38.3M (+33% YoY) 
  - Free Cash Flow: $160M (34% margin) 
- **2026 Guidance**: 
  - ARR: $567-573M (18-19% growth) 
  - Revenue: $565-571M (19-20% growth) 
  - Adjusted EBITDA: $149-155M (26-27% margin) 
  - Free Cash Flow Margin >30% 
- **Key Drivers**: 
  - Core growth (17% organic in 2025) 
  - Inseyets conversions and unlock business 
  - Guardian and Corellium solutions (2.5x growth vs. overall business) 
- **Challenges**: 
  - 1pt margin compression from Corellium costs 
  - FX headwinds (shekel strength) 

**【Q&A Highlights】**
- **Acquisition Execution**: 
  - SCG Canada expected to close Q1 2026, with ARR <$10M but high growth potential. 
  - Corellium integration progressing well, with go-to-market training completed. 
- **Federal Market Recovery**: 
  - U.S. Federal unit to exceed company-wide growth in 2026, driven by: 
    - FedRAMP Level 4 ATO for Guardian 
    - Defense/intel funding increases 
    - 9PB storage contract in pipeline 
- **AI Strategy**: 
  - Developing agentic applications for cold case investigations, child exploitation, and cybercrime. 
  - AI adoption expected to improve gross retention and operational efficiency. 
- **Sales Expansion**: 
  - 20% increase in salesforce focused on: 
    - Public safety (medium/small agencies) 
    - Enterprise mobile security (financial services) 
    - Defense/intelligence (Corellium integration) 
- **Drone Forensics**: 
  - SCG acquisition positions Cellebrite as leader in $53B drone market, with customer demand validated in defense and law enforcement sectors.

Cellebrite DI Ltd. (CLBT) Q4 2025 Earnings Call Transcript

- **ARR Growth Acceleration**: Q3 ARR up 19% YoY to $440 million, with subscription revenue driving 21% growth. 2025 EBITDA guidance raised to $124-127 million.
- **Federal Segment Turnaround**: U.S. federal ARR returned to growth, with key wins in defense and intelligence. 2026 federal recovery supported by Corellium and FedRAMP.
- **SaaS Momentum**: Guardian ARR grew over 100% QoQ, with 50%+ customers using the platform. Guardian Investigate launch in Q1 2026 targets multi-source data workflows.
- **Corellium Confidence**: $150 million acquisition nearing close, with $10+ million ARR pipeline across defense, intelligence, and enterprise.
- **Profitability Expansion**: Gross margin 84.5%, adjusted EBITDA margin 29.9%. 2025 free cash flow margin expected at 30%.

**【CEO Summary Section】**
- **ARR Growth**: Q3 ARR reached $440 million, up 19% YoY, driven by subscription revenue growth of 21%. U.S. state/local and Latin America segments led performance.
- **Subscription Momentum**: 89% of revenue came from subscription-based solutions, with Inseyets conversions at 47% of the installed base (target 50% by year-end).
- **Federal Segment Recovery**: U.S. federal ARR returned to growth, with key wins in defense and intelligence agencies. Corellium acquisition (expected Q4 close) positions for 2026 federal expansion.
- **AI and SaaS Innovation**: Guardian SaaS ARR grew over 100% QoQ, with Guardian Investigate set to launch in Q1 2026. Pathfinder remains critical for on-prem analytics, while Guardian Investigate targets multi-source data workflows.
- **Defense & Intelligence Expansion**: D&I ARR growth exceeded 100% YoY, with European agencies leading adoption of advanced unlock and decryption solutions.

**【CFO Financial Commentary】**
- **Revenue & Profitability**: Q3 revenue $126 million (+18% YoY), gross margin 84.5%, adjusted EBITDA $37.7 million (+20% YoY). Full year 2025 EBITDA guidance raised to $124-127 million.
- **Cash Flow**: Free cash flow $30 million (Q3) and $140 million trailing 12 months, with 30% free cash flow margin expected for 2025.
- **2026 Outlook**: Anticipates ARR growth acceleration, driven by Inseyets upgrades, Guardian adoption, and Corellium integration. EBITDA margin expansion through AI-enabled efficiency gains.

**【Q&A Key Highlights】**
- **Corellium Update**: CFIUS clearance nearing completion, with $150 million purchase expected Q4. Pipeline exceeds $10 million ARR across defense, intelligence, and enterprise.
- **Federal Execution**: Q3 federal growth included $11 million+ orders from marquee agencies. 2026 federal recovery supported by FedRAMP authorization and Corellium product fit.
- **SaaS Transition**: 50%+ of customers using Guardian, with hybrid deployments common. Pathfinder remains critical for high-volume on-prem analytics.
- **Cash Allocation**: Post-Corellium, focus on disciplined M&A and AI investments to maintain 30%+ free cash flow margin.


Cellebrite DI Ltd. (CLBT) Q3 2025 Earnings Call Transcript

- **Revenue & ARR Growth**: Q2 ARR +21% to $419M, revenue +18% to $113.3M, with 91% from subscriptions.
- **Strategic Wins**: Guardian ARR doubles YoY; Corellium acquisition ($150M) closes first $500K deal in Europe.
- **Federal Challenges**: 2025 federal ARR growth reduced by 4pts due to delays, but renewals >95%.
- **AI & Innovation**: GenAI integration across products; mobile research updates cover 100+ Android OEMs.
- **2026 Outlook**: Potential 20%+ ARR growth driven by FedRAMP ATO, D&I spending, and Corellium adoption.


**【CEO Summary Section】**
- **Revenue Growth**: Q2 ARR grew 21% to $419 million, driven by U.S. state/local and Latin America. Revenue increased 18% to $113.3 million, with 91% from subscriptions.
- **Strategic Achievements**: 
  - Inseyets adoption reached 40% of license base; Guardian ARR grew 100% YoY for the 4th consecutive quarter.
  - Corellium acquisition ($150M) to expand ARM-based vulnerability testing, closing first $500K deal in Europe.
  - FedRAMP ADO for Government Cloud solutions with DOJ sponsorship, enabling federal sales.
- **Federal Challenges**: U.S. federal ARR growth reduced by 4pts due to delayed spending, though renewals remain strong (mid-90% retention). Expect resurgence in 2026 post-legislation.
- **AI & Innovation**: Integrating GenAI across products (e.g., Guardian) to enhance investigation efficiency; mobile research updates cover 100+ Android OEMs.

**【CFO Financial Commentary】**
- **Profitability**: Gross margin 85%, adjusted EBITDA $27.9M (+29% YoY), free cash flow $29M (25.6% margin).
- **Balance Sheet**: $558M cash, up $48M QoQ. Free cash flow expected at ~30% margin for 2025.
- **Guidance**: 
  - Q3 ARR: $435-445M (17-20% growth)
  - Full year ARR: $460-475M (16-20% growth)
  - Full year revenue: $465-475M (16-18% growth)
  - Adjusted EBITDA: $118-123M (25-26% margin)

**【Q&A Key Highlights】**
- **Federal Spending Confidence**: Renewal rates >95%, pipeline strong, but timing uncertain. First deal under new legislation closed Q2, with 2x renewal expected.
- **Corellium Impact**: Early interest from defense/intel agencies; potential to expand private sector use cases.
- **2026 Outlook**: FedRAMP ATO, D&I spending growth, and Corellium adoption could drive 20%+ ARR growth.
- **AI Integration**: Using AI for internal efficiency (e.g., sales forecasting) and external solutions (e.g., evidence analysis bots).
- **Europe Momentum**: D&I spending growth in EMEA, with Guardian and Pathfinder adoption accelerating.


Cellebrite DI Ltd. (CLBT) Q2 2025 Earnings Call Transcript

- **ARR growth outperforms expectations**: 23% YoY driven by state/local, Latin America, and Asia Pacific.
- **Federal recovery optimism**: Expanded pipeline and Q3 seasonality may offset short-term headwinds.
- **Insights migration momentum**: 30% of installed base converted, targeting 50% by year-end.
- **Guardian hyper-growth**: ARR up >100% QoQ, tripling year-over-year customer count.
- **Long-term vision reaffirmed**: $1 billion ARR by 2028 with 20% CAGR, supported by D&amp;I and private sector expansion.

**【CEO Summary Section】**
- Q1 ARR grew 23% YoY to $408 million, driven by strong performance in U.S. state/local, Latin America, and Asia Pacific. Adjusted EBITDA increased 34% to $23.7 million, with a 22% margin.
- Federal segment represented 17% of 2024 revenue but faced short-term headwinds; pipeline expansion and Q3 seasonality may drive H2 recovery.
- 30% of installed base migrated to Insights, on track for 50% conversion by end-2025. Guardian ARR growth exceeded 100% for the third consecutive quarter.
- User conference in Washington D.C. attracted 700 attendees, and EMEA go-to-market investments are expected to accelerate growth in H2.

**【CFO Financial Commentary】**
- Q1 revenue of $107.5 million (+20% YoY) reflected 21% subscription growth, with 89% of revenue from recurring sources.
- Gross margin of 84.4% (down 130bps YoY) due to hosting and customer success investments. Operating expenses rose 13% to $68.8 million, driven by headcount and event costs.
- Q2 guidance: ARR $416-426 million (+20-23% YoY), revenue $110-116 million (+15-21% YoY). Full-year ARR and EBITDA targets remain unchanged.

**【Q&A Key Points】**
- Federal market: Pipeline expansion and Memorial Day budget resolution could unlock Q3 spending. FedRAMP ATO expected by Q3, positioning for 2026 growth.
- EMEA: Board/executive team visits to U.K. and Germany signal commitment; pipeline growth and customer engagement suggest H2 acceleration.
- Pathfinder: 10.4 release enhanced cloud delivery; penetration target 25% vs. 50% for Guardian, constrained by sovereign cloud adoption.
- Long-term vision: $1 billion ARR by 2028 (20% CAGR) remains intact, with D&amp;I and private sector as key growth drivers.


Cellebrite DI Ltd. (CLBT) Q1 2025 Earnings Call Transcript

- **2024 Growth Milestones**: 25% ARR growth, 25% EBITDA margin, $122M free cash flow. 
- **2025 Targets**: 21-25% ARR growth, 20-22% revenue growth, 24-25% EBITDA margin. 
- **Strategic Priorities**: 
  - Migrate 50%+ to Inseyets by end-2025. 
  - Expand cloud ARR to 17% of total. 
  - Double federal TAM with FedRAMP certification. 
  - Host 500+ attendee Case-to-Closure Summit. 
- **Key Risks**: Q1 2025 federal pipeline delays ($2-3M impact). 
- **Customer Loyalty**: 92% retention in 2024; targeting 0.5-1% improvement. 


**【CEO Summary Section】**
- **2024 Performance Highlights**: Delivered 25% ARR growth to $396 million, 25% adjusted EBITDA margin, and $122 million free cash flow. Achieved Rule of 50 with 25% ARR growth and 25% EBITDA margin. 
- **2025 Strategic Priorities**: 
  - Migrate 50%+ of installed base to Inseyets (up from 20% in 2024). 
  - Expand cloud-based ARR to 17% of total (doubled from 2023). 
  - Grow Guardian/Pathfinder ARR by 50%+ (now 10% of total). 
  - Launch FedRAMP-compliant Cellebrite Federal Solutions. 
  - Host inaugural Case-to-Closure Summit in March 2025. 
- **CEO Search Update**: Actively interviewing candidates with SaaS/AI expertise; no timeline set. 

**【CFO Financial Commentary】**
- **Q4 2024 Results**: 
  - Revenue: $109 million (17% YoY growth). 
  - ARR: $396 million (25% YoY). 
  - Gross Margin: 85% (up from 84.2% in 2023). 
  - Adjusted EBITDA: $28.8 million (26% margin). 
  - Free Cash Flow: $61.7 million (59% YoY increase). 
- **2025 Outlook**: 
  - ARR: $480-495 million (21-25% growth). 
  - Revenue: $480-490 million (20-22% growth). 
  - EBITDA: $113-123 million (24-25% margin). 
  - Diluted Shares: 255-265 million. 
- **Key Drivers**: Subscription software growth, Inseyets migration, federal sector expansion. 

**【Q&A Key Questions】**
1. **Federal Spending Impact**: 
  - 20% of revenue from U.S. federal; no impact on renewals. 
  - Q1 2025 guidance includes $2-3 million headwinds from regime changes. 
  - Long-term opportunity to double TAM with FedRAMP certification. 
2. **Inseyets Migration Progress**: 
  - 20% of installed base migrated in 2024 (vs. 10% target). 
  - Target 50%+ by end of 2025. 
  - Unlock attach rate at 30%+ (up from 20% in 2023). 
3. **AI Adoption**: 
  - Gen AI features in Guardian enable 10x faster analysis. 
  - 60% of customers see AI as critical for combating digital crime. 
4. **Customer Retention**: 
  - 92% gross retention in 2024 (up from 88% in 2023). 
  - 2025 target: 0.5-1% improvement from reduced voluntary exits. 


Actual	0.08	0.25	0.27	0.17	0.13	0.04	-0.21	-0.17	0.03	-0.08	-0.36	-0.12	-0.99	0.08	0.07	0.08	0.08	0.08
Forecast	0.0067	0.0175	0.0125	0.0136	0.005	0.0525	0.0079	0.0152	0.0256	0.032	0.0242	0.0363	0.0747	0.0687	0.0525	0.0771	0.0945	0.0974
Surprise	+1094.03%	+1328.57%	+2060.00%	+1150.00%	+2500.00%	-23.81%	-2758.23%	-1218.42%	+17.19%	-350.00%	-1587.60%	-430.58%	-1425.30%	+16.45%	+33.33%	+3.76%	-15.34%	-17.86%

CLBT

CLBT fundamentals

CLBT Q4 2025 Earnings

Earnings Call

You can ask Aime

CLBT

CLBT fundamentals

CLBT Q4 2025 Earnings

Earnings Call

CLBT Earnings Call Summary for Q4/20258:30 AM on Feb 11, 2026

CLBT Earnings Call Summary for Q3/20255:00 PM on Nov 12, 2025

CLBT Earnings Call Summary for Q2/20258:30 AM on Aug 14, 2025

CLBT Earnings Call Summary for Q1/20258:30 AM on May 14, 2025

CLBT Earnings Call Summary for Q4/20248:30 AM on Feb 13, 2025

You can ask Aime